Business Context and Reporting Period
Company: Flowserve Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: January 11, 2012
Reporting Period: Fourth quarter and full year ended December 31, 2011
Key Financial Metrics
The filing references a press release (Exhibit 99.1) containing specific financial data but does not explicitly state the values within the text of this 8-K form.
- Bookings: Announced for Q4 and full year 2011 (specific figures not provided in this text).
- Cash Balance: Reported as of December 31, 2011 (specific figure not provided in this text).
- Earnings Per Share (EPS) Guidance: Reaffirmed target range of $7.45 to $7.85 for the full year 2011.
- Revenue, Profit, Margins, Debt: The filing text does not provide clear values for these metrics.
Material Changes and Management Commentary
Leadership Restructuring
The Company unified its operational leadership structure with the following changes:
- Thomas L. Pajonas: Promoted from Senior Vice President and President of the Flow Control Division to the newly created position of Senior Vice President and Chief Operating Officer. He will oversee all Company operations (Flow Control Division and Flow Solutions Group) and report to CEO Mark Blinn.
- Thomas E. Ferguson: Former Senior Vice President and President of the Flow Solutions Group, will retire at the end of 2012. He will serve in a special advisory role to Mr. Blinn until retirement.
- Michael S. Taff: Incoming Senior Vice President and Chief Financial Officer, formally beginning employment on January 16, 2012.
No modifications to Mr. Pajonas' current compensation package have been made at this time.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated January 11, 2012) for specific Q4 and full-year 2011 booking figures and cash balance details.
- Verify the impact of the leadership transition on operational strategy and execution.
- Monitor the formal start date and integration of the new CFO, Michael S. Taff.
- Confirm the final 2011 EPS results against the reaffirmed guidance range of $7.45 to $7.85.